Monitoring imatinib decreasing pericyte coverage and HIF-1α level in a colorectal cancer model by an ultrahigh-field multiparametric MRI approach.

J Transl Med · 2024 · PMC11293104 · PMID 39085929

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In the imatinib group, intratumor PDGFRβ + pericyte coverage and α-SMA + pericyte coverage both showed a decreasing trend (Fig. 5 B; Tables 2 and 3 ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.